INSMED Inc (INSM)
INSMED Inc (INSM) is a Healthcare stock tracked by StreetAlpha. INSM reports earnings on Thu, Oct 29, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 10 firms (10 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in INSM, 100% of them bullish and 0% bearish. In the past 30 days there were 10 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 12 | HC Wainwright & Co. | Reiterated | Buy | — |
| Sep 30 | Barclays | Maintained | Buy | — |
| Sep 24 | Goldman Sachs | Reinstated | Buy | — |
| Sep 15 | Roth Capital | Reiterated | Buy | — |
| Aug 10 | JP Morgan | Target lowered | Buy | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether INSM is in one of them and how their past INSM trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered INSM in an article yet. Here's the latest on the wider market.
INSM Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Donald J TrumpExecutive branch | Buy | $15K – $50K | Jul 17, 2026 | Sep 22, 2026 | 67 d |
| Josh GottheimerD · NJ | Sell (partial) | $1K – $15K | Jun 10, 2026 | Jul 7, 2026 | 27 d |
| Gilbert CisnerosD · CA | Sell | $1K – $15K | Oct 3, 2025 | Nov 18, 2025 | 46 d |
| Gilbert CisnerosD · CA | Sell (partial) | $1K – $15K | Sep 22, 2025 | Oct 10, 2025 | 18 d |
| Gilbert CisnerosD · CA | Sell (partial) | $1K – $15K | Aug 8, 2025 | Sep 12, 2025 | 35 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.


